Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous immunoglobulin for COVID-19 infection
IRCT20200418047116N1Phase 2Completed
- Sponsor
- Gonabad University of Medical Sciences
- Start
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of immune globulin in coronavirus disease 2019 (COVID-19), sponsored by Gonabad University of Medical Sciences. Started Mar 2020; status: completed.
02
Drugs
immune globulin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200418047116N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200418047116N1.